| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |